Page 66 - Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu

Toksoplazmoz Tanı ve Tedavi Uzlaşı Raporu

böbreklerde T. gondii gösterilememiştir. Genel ölüm oranı %64 7. Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S, et al. In-
iken, tedavi edilen 11 hastanın 10’u hayatta kalmış ve erken fectious complications among 620 consecutive heart transplant patients
tanı ile tedavinin önemi vurgulanmıştır. Böbrek nakli alıcıla- at Stanford University Medical Center. Clin Infect Dis 2001;33(5):629-40.
https://doi.org/10.1086/322733
rında fulminan dissemine toksoplazmoz vakaları ne yazık ki, 8. Baden LR, Katz JT, Franck L, Tsang S, Hall M, Rubin RH, et al. Successful
ölümden sonra beklenmedik bir şekilde teşhis edilmiştir (16). toxoplasmosis prophylaxis after orthotopic cardiac transplantation with
Aynı donörden böbrek allogreftlerinin iki alıcısında akut tok- trimethoprim-sulfamethoxazole. Transplantation 2003;75(3):339-43.
soplazmoz meydana geldiği gösterilirken, koryoretinit, böbrek https://doi.org/10.1097/01.TP.0000044864.99398.F1
nakli yapılan bir hastada toksoplazmozun ortaya çıkan belirtisi 9. Muñoz P, Arencibia J, Rodríguez C, Rivera M, Palomo J, Yañez J, et al. Tri-
olarak rapor edilmiştir. methoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart
transplant recipients. Clin Infect Dis 2003;36(7):932-3; author reply 3.
Pneumocystis pnömonisini önlemek için öncelikle transplan- https://doi.org/10.1086/368209
tasyon ekipleri tarafından kullanılan TMP-SMX profilaksisi, 10. Wreghitt TG, Gray JJ, Pavel P, Balfour A, Fabbri A, Sharples LD, et al. Effica-
toksoplazmozun önlenmesinde başarılı olmuştur. Profilaksiye cy of pyrimethamine for the prevention of donor-acquired Toxoplasma
geç başlamak, transplantasyondan hemen sonra yeterli profi- gondii infection in heart and heart-lung transplant patients. Transpl Int
laksiye başlanması durumu ile karşılaştırıldığında, beklenen- 1992;5(4):197-200. https://doi.org/10.1111/j.1432-2277.1992.tb01745.x
den çok daha fazla toksoplazmoz vakasıyla sonuçlanabilir. 11. Kauffman HM, McBride MA, Delmonico FL. First report of the United
Bu sorun, risk altındaki hastaların PZR ile izlenmesinin ve bu Network for Organ Sharing Transplant Tumor Registry: Donors with
a history of cancer. Transplantation 2000;70(12):1747-51. https://doi.
hastalarda profilaksi için ek ilaçların belirlenmesinin önemini org/10.1097/00007890-200012270-00014
vurgulamaktadır (17).
12. Luft BJ, Naot Y, Araujo FG, Stinson EB, Remington JS. Primary and reacti-
vated toxoplasma infection in patients with cardiac transplants. Clinical
KaynaKlar spectrum and problems in diagnosis in a defined population. Ann Intern
Med 1983;99(1):27-31. https://doi.org/10.7326/0003-4819-99-1-27
1. Montoya JG, Gomez CA. Toxoplasmosis after solid organ transplan- 13. Bouton TC, Chan PA, Fort GG .Toxoplasmosis. Ferri’s Clinical Advisor.
tation. Transplant infections: Springer; 2016; p. 781-93. https://doi. 1503-1507.e1, 2022.
org/10.1007/978-3-319-28797-3_43
14. Fernàndez-Sabé N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M,
2. Khurana S, Batra N. Toxoplasmosis in organ transplant recipients: Evalu- et al. Risk factors, clinical features, and outcomes of toxoplasmosis in sol-
ation, implication, and prevention. Trop Parasitol 2016;6(2):123. https:// id-organ transplant recipients: A matched case-control study. Clin Infect
doi.org/10.4103/2229-5070.190814
Dis 2012;54(3):355-61. https://doi.org/10.1093/cid/cir806
3. Wolfe C, Wilk A, Tlusty S, Sifri C, Morris M, Mehta A, et al. editors. Do-
nor-Derived Toxoplasmosis in Solid Organ Transplant 2008-2015: Op- 15. Renoult E, Georges E, Biava M-F, Hulin C, Frimat L, Hestin D, et al. Toxo-
portunities for Improvement. American Journal of Transplantation; plasmosis in kidney transplant recipients: Report of six cases and review.
2016. Clin Infect Dis 1997;24(4):625-34. https://doi.org/10.1093/clind/24.4.625
16. Hamza A, Anderson IJ, Al-Khafaji B. Respiratory distress of unknown eti-
4. Fishman JA. Pneumocystis carinii and parasitic infections in trans-
plantation. Infect Dis Clin North Am 1995;9(4):1005-44. https://doi. ology in a transplant recipient: Think toxoplasmosis! Autops Case Rep
org/10.1016/S0891-5520(20)30713-3 2017;7(4):37-41. https://doi.org/10.4322/acr.2017.038
17. Gajurel K, Dhakal R, Montoya JG. Toxoplasma prophylaxis in hae-
5. Derouin F, Pelloux H; ESCMID Study Group on Clinical Parasitolo-
gy. Prevention of toxoplasmosis in transplant patients. Clin Micro- matopoietic cell transplant recipients: a review of the literature and
biol Infect 2008;14(12):1089-101. https://doi.org/10.1111/j.1469- recommendations. Curr Opin Infect Dis 2015;28(4):283-92. https://doi.
0691.2008.02091.x org/10.1097/QCO.0000000000000169
6. Gallino A, Maggiorini M, Kiowski W, Martin X, Wunderli W, Schneider J,
et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol
Infect Dis 1996;15(5):389-93. https://doi.org/10.1007/BF01690095

57